Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-11-18 00:00:00 ET · period of report 2024-11-18 · accession 0001415889-24-027107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-18 | 2024-11-18 | FENC | Andrade Robert | CFO | M - OptEx | $2.45 | +15.8K | 127.4K | +14% | +$38.7K |
| D | 2024-11-18 | 2024-11-18 | FENC | Andrade Robert | CFO | M - OptEx | $2.45 | -15.8K | 689.2K | -2% | -$38.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2024-11-18 | M | A | 15,816 | $2.45 | 127,381 | D | — | — | (F1) Shares acquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026 |
| 2 | Derivative | Stock Options | 2024-11-18 | M | D | 15,816 | $2.45 | 689,184 | D | $2.45 · 2016-07-05 to 2026-07-05 | 15,816 Options | (F2) Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026 |